MPHMF (Callitas Health) Institutional Ownership : 0.00% (As of Dec. 03, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Callitas Health Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Callitas Health's institutional ownership is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Callitas Health's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Callitas Health's Float Percentage Of Total Shares Outstanding is 0.00%.

Callitas Health Institutional Ownership Historical Data

The historical data trend for Callitas Health's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Callitas Health Institutional Ownership Chart

Callitas Health Annual Data

Trend

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Institutional Ownership

Get a 7-Day Free Trial

Callitas Health Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
Institutional Ownership	Get a 7-Day Free Trial															-	-	-	-	-

Callitas Health Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Callitas Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Callitas Health Inc (OTCPK:MPHMF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

734 - 1055 Dunsmuir Street, Vancouver, BC, CAN, V7X 1B1

Website

http://www.callitas.com

Callitas Health Inc is a clinical-stage company. It is engaged in developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The company's products offering includes ToConceive, C-103 Reformulated Orlistat, and Extrinsa. ToConceive is a fertility enhancing moisturizer. It is clinically proven to increase a woman's own natural conception lubrication, called transudate, to aid in conception. Orlistat is FDA-approved for weight management and sold by Roche as Xenical (prescription) and by GlaxoSmithKline as alli. Extrinsa focuses on women with orgasm and arousal difficulties. The topical, local, and the non-systemic product is also non-hormonal and does not affect the central nervous system.